BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17638170)

  • 1. [FDG-PET-CT based imaging of retropharyngeal lymph nodes with its impact on radiotherapy].
    Dietl B; Marienhagen J; Murthum T; Kölbl O
    Laryngorhinootologie; 2008 Jan; 87(1):39-42. PubMed ID: 17638170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference].
    Kohlfürst S; Markitz M; Raunik W; Eckel HE; Kresnik E; Hausegger K; Salzwimmer M; Gaggl A; Chiari F; Lind P
    Laryngorhinootologie; 2009 Feb; 88(2):84-90. PubMed ID: 19219754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer.
    Everitt C; Leong T
    Australas Radiol; 2006 Jun; 50(3):271-4. PubMed ID: 16732830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated image fusion of dedicated PET and CT for external beam radiation and therapy in the head and neck area.
    Vogel WV; Schinagl DA; Van Dalen JA; Kaanders JH; Oyen WJ
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):74-83. PubMed ID: 17380097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
    Richard C; Prevot N; Timoshenko AP; Dumollard JM; Dubois F; Martin C; Prades JM
    Acta Otolaryngol; 2010 Dec; 130(12):1421-4. PubMed ID: 20735322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
    Dietz A; Rudat V; Harms W; Jungehülsing M; Dollner R; Henze M
    HNO; 2004 Jan; 52(1):38-44. PubMed ID: 14740113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
    Chan SC; Lin CY; Ng SH; Chang JT; Wang HM; Liao CT; Lo CW; Yen TC
    Nucl Med Commun; 2010 Mar; 31(3):260-5. PubMed ID: 20072075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Target volume including the nasopharynx for radiotherapy of hypopharyngeal squamous cell carcinoma: whether or not].
    Li Q; Xu T; Hu WH; Gu MF; Gao YH; Wang HY; Wang F; Cai XY; Ge N
    Ai Zheng; 2009 May; 28(5):515-9. PubMed ID: 19624881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using CT or MRI to assess locoregional spread to determine the radiotherapy target of hypopharyngeal carcinoma.
    Wu Z; Deng XY; Zeng RF; Su Y; Gu MF; Zhang Y; Xie CM; Zheng L
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e21-7. PubMed ID: 22897935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for retropharyngeal lymph node metastasis in carcinoma of the hypopharynx.
    Wu Z; Deng XY; Zeng RF; Su Y; Gu MF; Zhang Y; Xie CM; Zheng L
    Head Neck; 2013 Sep; 35(9):1274-7. PubMed ID: 22907638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.